• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对氟伏沙明有反应的强迫症患者丘脑血流减少。

Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.

作者信息

Ho Pian Kamini L, van Megen Harold J G M, Ramsey Nick F, Mandl René, van Rijk Peter P, Wynne H J, Westenberg Herman G M

机构信息

Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.

出版信息

Psychiatry Res. 2005 Feb 28;138(2):89-97. doi: 10.1016/j.pscychresns.2004.12.003.

DOI:10.1016/j.pscychresns.2004.12.003
PMID:15766633
Abstract

Functional imaging studies have pointed to a role of the orbitofrontal cortex (OFC), striatum and thalamus in the pathophysiology of obsessive-compulsive disorder (OCD). Effective treatment has been found to change brain activity within this circuitry. The aim of the present study was to explore possible differential effects of OCD responders and non-responders to drug treatment on the regional cerebral blood flow (rCBF). Measurements of rCBF were carried out in 15 out of 22 patients with OCD who completed an open-label trial with fluvoxamine. Patients were studied with 99mTc-HMPAO single photon emission computed tomography (SPECT) before and after 12 weeks of treatment. In addition, structural magnetic resonance imaging was obtained on all patients. Regions of interest comprised the OFC, caudate nucleus, putamen and thalamus. Seven patients responded to treatment. Levels of rCBF decreased significantly in the left caudate nucleus and the left and right putamen in both responders and non-responders to treatment. In responders, but not in non-responders, a significant decrease in rCBF was found in the right thalamus. Pre-treatment cerebellar and whole brain HMPAO uptake was significantly higher in responders to treatment compared with non-responders. We suggest that the thalamus plays a central role in the response to drug treatment.

摘要

功能成像研究表明,眶额皮质(OFC)、纹状体和丘脑在强迫症(OCD)的病理生理学中发挥作用。已发现有效治疗可改变该神经回路内的脑活动。本研究的目的是探讨强迫症患者对药物治疗的反应者和无反应者对局部脑血流(rCBF)可能产生的不同影响。对22例完成氟伏沙明开放标签试验的强迫症患者中的15例进行了rCBF测量。在治疗12周前后,对患者进行了99mTc-HMPAO单光子发射计算机断层扫描(SPECT)检查。此外,对所有患者进行了结构磁共振成像检查。感兴趣区域包括眶额皮质、尾状核、壳核和丘脑。7例患者对治疗有反应。治疗反应者和无反应者的左侧尾状核以及左侧和右侧壳核的rCBF水平均显著下降。在治疗反应者中,右侧丘脑的rCBF显著下降,而无反应者则未出现这种情况。治疗反应者治疗前小脑和全脑HMPAO摄取量显著高于无反应者。我们认为,丘脑在药物治疗反应中起核心作用。

相似文献

1
Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine.对氟伏沙明有反应的强迫症患者丘脑血流减少。
Psychiatry Res. 2005 Feb 28;138(2):89-97. doi: 10.1016/j.pscychresns.2004.12.003.
2
The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder.强迫症患者治疗前后 (99m)Tc HMPAO 脑 SPECT 影像比较。
Psychiatry Res. 2013 Aug 30;213(2):169-77. doi: 10.1016/j.pscychresns.2012.07.005. Epub 2012 Nov 11.
3
Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.强迫症患者静息状态下的局部脑血流量。与强迫和焦虑回避维度的差异相关性。
Br J Psychiatry. 1995 Nov;167(5):629-34. doi: 10.1192/bjp.167.5.629.
4
Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study.强迫症患者丘脑和前额叶区域脑血流量增加:一项单光子发射计算机断层扫描研究。
Psychiatry Res. 2003 Jun 30;123(2):125-34. doi: 10.1016/s0925-4927(03)00061-1.
5
Pharmacotherapy response and regional cerebral blood flow characteristics in patients with obsessive-compulsive disorder.强迫症患者的药物治疗反应及局部脑血流特征
Behav Brain Funct. 2013 Jul 30;9:31. doi: 10.1186/1744-9081-9-31.
6
Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.西酞普兰治疗前后焦虑症的单光子发射计算机断层扫描(SPECT)
BMC Psychiatry. 2004 Oct 14;4:30. doi: 10.1186/1471-244X-4-30.
7
Regional 133xenon cerebral blood flow and cerebral 99mTc-HMPAO uptake in patients with obsessive-compulsive disorder before and during treatment.强迫症患者治疗前及治疗期间的局部133氙脑血流量和脑99mTc-HMPAO摄取情况。
Biol Psychiatry. 1995 Oct 1;38(7):429-37. doi: 10.1016/0006-3223(94)00305-m.
8
Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.强迫症患儿的药物治疗与局部脑血流
Yonsei Med J. 2004 Feb 29;45(1):90-9. doi: 10.3349/ymj.2004.45.1.90.
9
Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.未用药的强迫症患者及匹配的正常对照受试者的局部氙133脑血流量和脑锝99m HMPAO摄取情况。通过高分辨率单光子发射计算机断层扫描测定。
Arch Gen Psychiatry. 1992 Sep;49(9):695-702. doi: 10.1001/archpsyc.1992.01820090023004.
10
Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study.
Neuropsychopharmacology. 2002 Nov;27(5):782-91. doi: 10.1016/S0893-133X(02)00351-2.

引用本文的文献

1
The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.《TTASAAN报告的遗产——草率结论与被遗忘的承诺:政策与实践回顾 第一部分》
Front Neurol. 2022 Mar 28;12:749579. doi: 10.3389/fneur.2021.749579. eCollection 2021.
2
The prefrontal cortex and OCD.前额叶皮质与强迫症。
Neuropsychopharmacology. 2022 Jan;47(1):211-224. doi: 10.1038/s41386-021-01130-2. Epub 2021 Aug 16.
3
Defining functional brain networks underlying obsessive-compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature.
使用治疗诱导的神经影像学变化来定义强迫症(OCD)的功能性大脑网络:文献系统综述。
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):776-786. doi: 10.1136/jnnp-2020-324478. Epub 2021 Apr 27.
4
Pharmacotherapeutic Strategies and New Targets in OCD.强迫症的药物治疗策略和新靶点。
Curr Top Behav Neurosci. 2021;49:331-384. doi: 10.1007/7854_2020_204.
5
Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder.儿童强迫症患者中治疗反应者、无反应者和对照组间尾状核体积的差异。
Eur Child Adolesc Psychiatry. 2019 Dec;28(12):1607-1617. doi: 10.1007/s00787-019-01320-w. Epub 2019 Apr 10.
6
Neuroimaging findings in obsessive-compulsive disorder: A narrative review to elucidate neurobiological underpinnings.强迫症的神经影像学研究结果:一项旨在阐明神经生物学基础的叙述性综述
Indian J Psychiatry. 2019 Jan;61(Suppl 1):S9-S29. doi: 10.4103/psychiatry.IndianJPsychiatry_525_18.
7
Pituitary gland volumes in patients with obsessive-compulsive disorder before and after cognitive-behavioral therapy.强迫症患者认知行为治疗前后的脑垂体体积。
Braz J Psychiatry. 2018 Oct-Dec;40(4):420-423. doi: 10.1590/1516-4446-2017-2449. Epub 2018 Jun 11.
8
Functional and Structural Neural Changes in Obsessive-compulsive Disorder after Pharmacotherapy.强迫症患者药物治疗后的功能和结构神经变化。
Curr Neuropharmacol. 2019;17(8):737-740. doi: 10.2174/1570159X16666180613074059.
9
Impact of treatment on resting cerebral blood flow and metabolism in obsessive compulsive disorder: a meta-analysis.治疗对强迫症患者静息态脑血流和代谢的影响:一项荟萃分析。
Sci Rep. 2017 Dec 12;7(1):17464. doi: 10.1038/s41598-017-17593-7.
10
A trans-diagnostic perspective on obsessive-compulsive disorder.关于强迫症的跨诊断视角。
Psychol Med. 2017 Jul;47(9):1528-1548. doi: 10.1017/S0033291716002786. Epub 2017 Mar 27.